Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension Analysis From the Dallas Heart Study

被引:160
|
作者
Tientcheu, Danielle [1 ]
Ayers, Colby [1 ]
Das, Sandeep R. [1 ]
McGuire, Darren K. [1 ]
de Lemos, James A. [1 ]
Khera, Amit [1 ]
Kaplan, Norman [1 ]
Victor, Ronald [2 ]
Vongpatanasin, Wanpen [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA
[2] Cedars Sinai Heart Inst, Hypertens Ctr, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
African Americans; arterial stiffness; blood pressure; multiethnic; outcome assessment (health care); HOME BLOOD-PRESSURE; INTERNATIONAL DATABASE; AFRICAN-AMERICANS; PROGNOSTIC VALUE; PREVALENCE; PREDICTORS; MORTALITY; SAMPLE; RISK;
D O I
10.1016/j.jacc.2015.09.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Multiple epidemiological studies from Europe and Asia have demonstrated increased cardiovascular risks associated with isolated elevation of home blood pressure (BP) or masked hypertension (MH). Previous studies have not addressed cardiovascular outcomes associated with MH and white-coat hypertension (WCH) in the general population in the United States. OBJECTIVES The goal of this study was to determine hypertensive target organ damage and adverse cardiovascular outcomes associated with WCH (high clinic BP, >= 140/90 mm Hg; normal home BP, <135/85 mm Hg), MH (high home BP, >= 135/85 mm Hg; normal clinic BP, <140/90 mm Hg), and sustained hypertension (high home and clinic BP) in the DHS (Dallas Heart Study), a large, multiethnic, probability-based population cohort. METHODS Associations among WCH, MH, sustained hypertension, and aortic pulsed wave velocity by magnetic resonance imaging; urinary albumin-to-creatinine ratio; and cystatin C were evaluated at study baseline. Then, associations between WCH and MH with incident cardiovascular outcomes (coronary heart disease, stroke, atrial fibrillation, heart failure, and cardiovascular death) over a median follow-up period of 9 years were assessed. RESULTS The study cohort comprised 3,027 subjects (50% African Americans). The sample-weighted prevalence rates of WCH and MH were 3.3% and 17.8%, respectively. Both WCH and MH were independently associated with increased aortic pulsed wave velocity, cystatin C, and urinary albumin-to-creatinine ratio. Both WCH (adjusted hazard ratio: 2.09; 95% confidence interval: 1.05 to 4.15) and MH (adjusted hazard ratio: 2.03; 95% confidence interval: 1.36 to 3.03) were independently associated with higher cardiovascular events compared with the normotensive group, even after adjustment for traditional cardiovascular risk factors. CONCLUSIONS In a multiethnic U.S. population, both WCH and MH were independently associated with increased aortic stiffness, renal injury, and incident cardiovascular events. Because MH is common and associated with an adverse cardiovascular profile, home BP monitoring should be routinely performed among U.S. adults. (C) 2015 by the American College of Cardiology Foundation.
引用
收藏
页码:2159 / 2169
页数:11
相关论文
共 50 条
  • [1] Subclinical target organ damage in masked and white-coat hypertension
    Arita, M
    Matsutani, Y
    Morioka, I
    Utsumi, M
    Suzuki, S
    Nakamura, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 336A - 336A
  • [2] Heart rate turbulence in masked hypertension and white-coat hypertension
    Song, C. -L.
    Zhang, X.
    Liu, Y. -K.
    Yue, W. -W.
    Wu, H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (08) : 1457 - 1460
  • [3] White-coat hypertension or white-coat hypertension syndrome: Which is accompanied by target organ damage?
    Kario, K
    Pickering, TG
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (22) : 3497 - 3498
  • [4] White-coat and masked hypertension in children: association with target-organ damage
    Stabouli, S
    Kotsis, V
    Toumanidis, S
    Papamichael, C
    Constantopoulos, A
    Zakopoulos, N
    PEDIATRIC NEPHROLOGY, 2005, 20 (08) : 1151 - 1155
  • [5] White-coat and masked hypertension in children: association with target-organ damage
    Stella Stabouli
    Vasilios Kotsis
    Savvas Toumanidis
    Christos Papamichael
    Andreas Constantopoulos
    Nikos Zakopoulos
    Pediatric Nephrology, 2005, 20 : 1151 - 1155
  • [6] Masked hypertension and white-coat hypertension prognosis
    Verberk, W
    Kroon, AA
    de Leeuw, PW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (10) : 2127 - 2127
  • [7] White-coat hypertension and masked hypertension: an update
    Artom, Nathan
    Salvo, Francesco
    Camardella, Francesca
    ITALIAN JOURNAL OF MEDICINE, 2016, 10 (02) : 96 - 102
  • [8] White-coat hypertension and masked hypertension in children
    Stergiou, GS
    Yiannes, NJ
    Rarra, VC
    Alamara, CV
    BLOOD PRESSURE MONITORING, 2005, 10 (06) : 297 - 300
  • [9] Target organ damage in "White coat hypertension" and "Masked hypertension"
    Kotsis, Vasilios
    Stabouli, Stella
    Toumanidis, Savvas
    Lekakis, John
    Germanidis, George
    Hatzitolios, Apostolos
    Rizos, Zoe
    Sion, Michael
    Zakopoulos, Nikos
    AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (04) : 393 - 399
  • [10] White-coat hypertension or white-coat hypertension syndrome:: Which is accompanied by target organ damage?: In reply
    Muldoon, MF
    Manuck, SB
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (22) : 3498 - 3498